INS and type 1 diabetes mellitus: The pooled analyses evaluating the pharmacokinetic and pharmacodynamic characteristics of Faster Aspart in adults with type 1 diabetes reported an earlier onset of appearance (5 min) after injection of Faster Aspart compared to Aspart and two times greater early insulin exposure calculated as AUC0-30 min ratio Faster Aspart/Aspart [37].